These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3822213)

  • 1. [Internal medicine evaluation of the surgical risk in cirrhosis patients].
    Gibertini P; Pietrangelo A; Coppo M
    Minerva Med; 1987 Feb; 78(3):151-8. PubMed ID: 3822213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trauma in the cirrhotic patient.
    Maull KI; Turnage B
    South Med J; 2001 Feb; 94(2):205-7. PubMed ID: 11235035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgery in the cirrhotic patient. Prognosis and risk factors].
    Pisani Ceretti A; Cordovana A; Pinto A; Spina GP
    Minerva Chir; 2000 Nov; 55(11):771-8. PubMed ID: 11265150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical approach to posthepatitic cirrhotic patient today].
    Meriggi F; Forni E
    G Chir; 1996; 17(6-7):370-8. PubMed ID: 9272983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical risks for cirrhotic patients].
    Fiaccadori F; Missale G; Pasetti GC; Pizzaferri P; Pedretti G
    Ann Ital Med Int; 1990; 5(2):140-6. PubMed ID: 2248863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of intractable ascites in cirrhotic patients by portal shunt].
    Franco D
    Gastroenterol Clin Biol; 1983 May; 7(5):533-9. PubMed ID: 6873567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study.
    Castells A; Saló J; Planas R; Quer JC; Ginès A; Boix J; Ginès P; Gassull MA; Terés J; Arroyo V
    Hepatology; 1994 Sep; 20(3):584-91. PubMed ID: 8076916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peroperative coagulation disorders in the cirrhotic patient and during partial hepatectomies].
    Thuot C; Pomier-Layrargues G; Lavoie P; Duguay L; Tanguay S; Huet PM; Villeneuve JP; Marleau D
    Union Med Can; 1984 Jun; 113(6):465-8. PubMed ID: 6485158
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation abnormalities in cirrhotic patients with portal vein thrombosis.
    Amitrano L; Guardascione MA; Ames PR
    Clin Lab; 2007; 53(9-12):583-9. PubMed ID: 18257465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease.
    Tacke F; Fiedler K; von Depka M; Luedde T; Hecker H; Manns MP; Ganser A; Trautwein C
    Liver Int; 2006 Mar; 26(2):173-81. PubMed ID: 16448455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation disorders in liver disease.
    Amitrano L; Guardascione MA; Brancaccio V; Balzano A
    Semin Liver Dis; 2002 Feb; 22(1):83-96. PubMed ID: 11928081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chest surgery in patients with liver disease].
    Yano T; Okamoto T
    Kyobu Geka; 2012 Jul; 65(8):734-7. PubMed ID: 22868438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
    Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
    Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of cirrhotic patients in extra-hepatic surgery.
    Franzetta M; Raimondo D; Giammanco M; Di Trapani B; Passariello P; Sammartano A; Di Gesù G
    Minerva Chir; 2003 Aug; 58(4):541-4. PubMed ID: 14603166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemostasis disorders in liver cirrhosis. 1. Pathogenesis, diagnosis].
    Neidhardt B; Schricker KT
    Fortschr Med; 1982 Apr; 100(14):626-30. PubMed ID: 7084848
    [No Abstract]   [Full Text] [Related]  

  • 16. Perioperative risk assessment for patients with cirrhosis and liver disease.
    Frye JW; Perri RE
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):65-75. PubMed ID: 19210114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic abnormalities in patients with liver disease associated with viral hepatitis.
    Pramoolsinsap C; Busagorn N; Kurathong S
    J Med Assoc Thai; 1996 Nov; 79(11):681-8. PubMed ID: 8997005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of nonshunt abdominal operation in the patient with cirrhosis.
    Wong R; Rappaport W; Witte C; Hunter G; Jaffe P; Hall K; Witzke D
    J Am Coll Surg; 1994 Oct; 179(4):412-6. PubMed ID: 7921390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.